These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 17266452)
1. Anidulafungin: a new echinocandin for candidal infections. de la Torre P; Reboli AC Expert Rev Anti Infect Ther; 2007 Feb; 5(1):45-52. PubMed ID: 17266452 [TBL] [Abstract][Full Text] [Related]
2. Anidulafungin: a novel echinocandin for candida infections. de la Torre P; Meyer DK; Reboli AC Future Microbiol; 2008 Dec; 3(6):593-601. PubMed ID: 19072176 [TBL] [Abstract][Full Text] [Related]
3. Anidulafungin: a new echinocandin with a novel profile. Vazquez JA Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology and antifungal properties of anidulafungin, a new echinocandin. Estes KE; Penzak SR; Calis KA; Walsh TJ Pharmacotherapy; 2009 Jan; 29(1):17-30. PubMed ID: 19113794 [TBL] [Abstract][Full Text] [Related]
6. The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Wagner C; Graninger W; Presterl E; Joukhadar C Pharmacology; 2006; 78(4):161-77. PubMed ID: 17047411 [TBL] [Abstract][Full Text] [Related]
7. Micafungin: a new echinocandin antifungal. Joseph JM; Jain R; Danziger LH Pharmacotherapy; 2007 Jan; 27(1):53-67. PubMed ID: 17192162 [TBL] [Abstract][Full Text] [Related]
8. Anidulafungin--state of affairs from a clinical perspective. Vehreschild JJ; Kümmerle T; Karthaus M; Cornely OA Mycoses; 2007; 50 Suppl 1():38-43. PubMed ID: 17394608 [TBL] [Abstract][Full Text] [Related]
9. Echinocandins: the newest class of antifungals. Sucher AJ; Chahine EB; Balcer HE Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014 [TBL] [Abstract][Full Text] [Related]
10. Emerging echinocandins for treatment of invasive fungal infections. Turner MS; Drew RH; Perfect JR Expert Opin Emerg Drugs; 2006 May; 11(2):231-50. PubMed ID: 16634699 [TBL] [Abstract][Full Text] [Related]
11. The echinocandins. Cappelletty D; Eiselstein-McKitrick K Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149 [TBL] [Abstract][Full Text] [Related]
12. Anidulafungin: when and how? The clinician's view. George J; Reboli AC Mycoses; 2012 Jan; 55(1):36-44. PubMed ID: 21668526 [TBL] [Abstract][Full Text] [Related]
14. Echinocandin antifungals: review and update. Morrison VA Expert Rev Anti Infect Ther; 2006 Apr; 4(2):325-42. PubMed ID: 16597212 [TBL] [Abstract][Full Text] [Related]
15. Anidulafungin: advantage for the newcomer? Rüping MJ; Vehreschild JJ; Farowski F; Cornely OA Expert Rev Clin Pharmacol; 2008 Mar; 1(2):207-16. PubMed ID: 24422646 [TBL] [Abstract][Full Text] [Related]
16. [Anidulafungin: a new echinocandin for the treatment of mycosis]. Del Palacio A Rev Iberoam Micol; 2008 Jun; 25(2):74-7. PubMed ID: 18473500 [TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal. Dowell JA; Knebel W; Ludden T; Stogniew M; Krause D; Henkel T J Clin Pharmacol; 2004 Jun; 44(6):590-8. PubMed ID: 15145966 [TBL] [Abstract][Full Text] [Related]
18. Micafungin: an evidence-based review of its place in therapy. de la Torre P; Reboli AC Core Evid; 2014; 9():27-39. PubMed ID: 24596542 [TBL] [Abstract][Full Text] [Related]
19. [The role of anidulafungin therapy in solid organ transplant recipients]. Fortún Abete J; Martín-Dávila P Rev Iberoam Micol; 2008 Jun; 25(2):129-33. PubMed ID: 18473508 [TBL] [Abstract][Full Text] [Related]